Hurthle Cell Cancer
Encapsulated Hurthle cell carcinoma recurrence predicted by presence of 4 foci of vascular invasion
Published in Cancer Weekly, June 12th, 2006
According to recent research published in the journal Cancer, "Follicular carcinomas of the thyroid gland, including its oncocytic variant (so-called Hurthle cell carcinoma), are subdivided into the indolent encapsulated ('minimally invasive') and the clinically aggressive widely invasive tumors. There are, however, cases of encapsulated follicular carcinoma that recur and metastasize."
"Identifying these cases at the time of diagnosis is crucial for prognostic and therapeutic considerations. Because to the authors'...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-06-12)
More Articles from Cancer Weekly
- Apoptosis
Melanoma apoptosis triggered by novel Bcl-x splice product, Bcl-x(AK) - Breast Cancer
Breast cancer risk increased in developing countries due to circadian disruption - Neuroblastoma
Poor neuroblastoma outcome could be due to high-level MRP1 expression - Acoustic Neuroma
Acoustic neuroma patients' quality of life used in timing of surgery - Adenocarcinoma
Adenocarcinoma of esophagus and gastroesophageal junction linked to alteration of 1q and 8p genes - Adenoviral Gene Therapy
Adenovirus-mediated gene expression is improved by a polyethylene glycol vehicle - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
